AACR President Philip D. Greenberg, MD, FAACR, and a panel of experts will review tips on how to communicate scientific advances to non-scientists, including the general public, underserved communities, policymakers, patients, and journalists.

A Saturday plenary session on early cancer biology and interception, chaired by Daniel D. De Carvalho, PhD, will be followed by a Sunday session focused on the Annual Meeting’s theme of “Inspiring Science, Fueling Progress, Revolutionizing Care.”

Christine A. Iacobuzio-Donahue, MD, PhD, will chair a Monday, April 8, plenary session on profiling tumor ecosystems in native tissue context. Additional plenary sessions will be held Tuesday and Wednesday.

Since 2014, the AACR has provided high-profile presentation experience and professional development opportunities for early-career scientists through the AACR Annual Meeting.

A record number of clinical trial results were submitted for presentation at the Annual Meeting this year, reflecting the rapid translation of novel treatment strategies from the labs to the clinic, said Clinical Trials Committee Co-Chairs Shivaani Kummar, MBBS, and Ryan B. Corcoran, MD, PhD.

The AACR Annual Meeting features a multidisciplinary scientific program focused on energizing and educating the cancer research community, transforming patients’ lives, and making progress toward preventing and curing cancer.

Program Chairs Keith T. Flaherty, MD, FAACR, and Christina Curtis, PhD, MSc, represent some of the many cancer research skillsets at the Annual Meeting.

AACR President Philip D. Greenberg, MD, FAACR, previews critical issues that will be addressed by experts in individual sessions and program tracks during the Annual Meeting.

The 2024 class joins a distinguished group of more than 300 scientific pioneers who have made significant and ongoing contributions toward the AACR’s mission to prevent and cure all cancers.